Barker, Peter

Barker EL, Peter EB, Petrecia HF, Grant SK (1978) Phenol poisoning due to contaminated drinking water. Arch Environ Health 33 89-94... 

Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991 324 781-8. 

CONTENTS Preface. Bruce E. Maryanoff and Cynthia A. Maryanoft. Novel An-tipsychotics with Unique D /5-HT1A Affinity and Minimal Extrapyramidal Side Effect Liability. Allen B. Reitz and Malcolm K. Scott. Antiplatelet and Antithrombotic Agents From Viper Venom Proteins, to Peptides and Peptidomimetics. to Small Organic Molecules, Peter L. Barker and Robert R. Webb. II. Discovery and Preclinical Development of the Serotonin Reuptake Inhibitor Sertraline, Willard M. Welch. Boronic Acid Inhibitors of Dipeptidyipeptidase IV A New Class of Immunosuppressive Agents, Roger J. Snow. Index. 

Echt, D., Liebson, P., Mitchell, L., Peters, R., Obias-Manno, D., Barker, A., Arensberg, D., Baker, A., Friedman, L., Greene, H., Juther, M., and Richardson, D., Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial, New England Journal of Medicine, Vol. 324, No. 12, 1991, pp. 781-788. 

JONGSMA, M.A., BARKER, P.L., PETERS, J., BOSCH, D., STIEKEMA, W.J., Adaptation of Spodoptera exigua larvae to plant proteinase inhibitors by induction of gut proteinase activity insensitive to inhibition, Proc. Natl. Acad. ScL USA, 1995,92, 8041-8045. 

Sato, T., Vries, R.G., Snippert, H.J., van de Wetering, M., Barker, N., Stange, D.E., van Es, J.H., Abo, A., Kujala, R, Peters, RJ., and Clevers, H. 2009. Single Lgr5 stem cells buUd crypt-viUus structures in vitro without a mesenchymal niche. Nature, 459 262-265. 

---